Physician profile
Peter A Ugolini
NPI 1821103193
$2,279.24
in general payments reported to CMS, 2019-2025
12 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $576 · 2021: $86.14 · 2022: $160 · 2023: $438 · 2024: $778 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $844.91 | 2020-2023 | |
| Zimmer Biomet Holdings, INC. | $677.34 | 2019-2024 | Rosa, Comprehensive Shoulder System, Signature |
| Stryker Corporation | $302.46 | 2023-2024 | Blueprint Patient Specific Instrumentation, Cobra, Aequalis Perform |
| Davol INC. | $139.84 | 2024 | Arista Ah Flexitip |
| Exactech, INC. | $86.14 | 2021 | |
| Ferring Pharmaceuticals INC. | $70.59 | 2022-2025 | Euflexxa |
| Bioventus LLC | $47.89 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Lightbody Medical Technologies INC | $29.91 | 2023-2024 | |
| Wright Medical Technology, INC. | $24.66 | 2019 | |
| Abbott Laboratories | $22.70 | 2025 | Proclaim |
| Linvatec Corporation | $18.68 | 2025 | Biobrace 23mm |
| Dynasplint Systems INC. | $14.12 | 2025 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ugolini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.